Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00772304 |
To compare patient perceptions of the sensory attributes, including taste and aftertaste, of Olopatadine relative to azelastine when administered as a single dose in patients with allergic rhinitis.
Condition | Intervention | Phase |
---|---|---|
Allergic Rhinitis |
Drug: Olopatadine 0.6% Drug: Azelastine 137mcg |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Crossover Assignment |
Estimated Enrollment: | 100 |
Study Start Date: | October 2008 |
Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Olopatadine 0.6%
|
Drug: Olopatadine 0.6%
single dose; 2 sprays per nostril
|
2: Active Comparator
Azelastine 137mcg
|
Drug: Azelastine 137mcg
single dose; 2 sprays per nostril
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Alcon Research ( Michael Edwards, PhD\Global Scientific Market Affairs ) |
Study ID Numbers: | SMA-08-21 |
Study First Received: | October 13, 2008 |
Last Updated: | November 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00772304 |
Health Authority: | United States: Institutional Review Board |
rhinitis |
Otorhinolaryngologic Diseases Respiratory Tract Infections Respiratory Tract Diseases Histamine phosphate |
Rhinitis Azelastine Olopatadine Histamine |
Anti-Inflammatory Agents Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Histamine Agents Anti-Asthmatic Agents Enzyme Inhibitors Anti-Allergic Agents |
Lipoxygenase Inhibitors Pharmacologic Actions Nose Diseases Histamine Antagonists Autonomic Agents Analgesics, Non-Narcotic Histamine H1 Antagonists Peripheral Nervous System Agents Histamine H1 Antagonists, Non-Sedating Antirheumatic Agents Bronchodilator Agents Central Nervous System Agents |